Kennedy’s potential ascent as HHS secretary brings promise for backers of alternative-health approaches, while skeptics say those treatments are often unproven.
Robert F. Kennedy Jr. has big plans for the FDA if he's confirmed as Secretary of Health and Human Services. FDA Commissioner Robert Califf explains why certain changes may not be that easy — or desirable.
The Donald Trump nominee’s dangerous anti-science views could lead to outbreaks of preventable diseases right in our state. | Opinion
President-elect Donald Trump's pick to lead HHS has a long history of discounting and peddling misinformation about the HPV vaccine.
If Democratic senators think leaving the door ajar for RFK Jr. will get them points for bipartisanship, I recommend they find those opportunities elsewhere.
The prospect of having vaccine skeptic Robert F. Kennedy Jr. in charge of the nation’s health policy has doctors speaking out to oppose his confirmation as U.S. Health and Human Services secretary. The Committee to Protect Health Care says it has more than 15,
including the CDC, that he would oversee. House Republicans had mixed reactions to Trump's announcement that he would nominate Robert F. Kennedy Jr. to be HHS secretary. New York City Eric Adams ...
Robert F. Kennedy Jr.'s statements about drinking raw milk have reignited the debate over food safety and government regulation. The well-known activist has put raw milk in the spotlight, a product that the FDA bans in much of the United States due to its high risk of bacterial contamination.
Donald Trump’s more controversial personnel choices have prompted fears that Tulsi Gabbard would compromise intelligence operations and Pam Bondi and Kash Patel would target political enemies over dangerous criminals.
The Trump administration has promised an overhaul of various government agencies. What will happen to the Health Department?
Following his win over Kamala Harris, Donald Trump has been assembling the administration for his second term in the White House.
Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los Angeles court next week,